688076 诺泰生物
已收盘 07-22 15:00:00
资讯
新帖
简况
北向资金7月19日净卖出诺泰生物38.13万股 连续5日减持
自选股智能写手 · 07-22 09:30
北向资金7月19日净卖出诺泰生物38.13万股 连续5日减持
新冠药物概念盘中跳水,诺泰生物跌0.13%
自选股智能写手 · 07-19
新冠药物概念盘中跳水,诺泰生物跌0.13%
CRO概念盘中跳水,诺泰生物跌0.48%
自选股智能写手 · 07-19
CRO概念盘中跳水,诺泰生物跌0.48%
非酒精性脂肪性肝炎(NASH)概念盘中跳水,微芯生物跌2.07%
自选股智能写手 · 07-18
非酒精性脂肪性肝炎(NASH)概念盘中跳水,微芯生物跌2.07%
北向资金7月17日净卖出诺泰生物36.55万股 连续3日减持
自选股智能写手 · 07-18
北向资金7月17日净卖出诺泰生物36.55万股 连续3日减持
诺泰生物:实控人提议实施2024年度中期分红
澎湃新闻 · 07-17
诺泰生物:实控人提议实施2024年度中期分红
诺泰生物最新公告:控股股东提议中期分红
证券之星 · 07-17
诺泰生物最新公告:控股股东提议中期分红
诺泰生物(688076.SH)实控人提议中期分红
智通财经 · 07-17
诺泰生物(688076.SH)实控人提议中期分红
诺泰生物:拟实施2024年中期分红 分红金额不超净利润30%
财通社 · 07-17
诺泰生物:拟实施2024年中期分红 分红金额不超净利润30%
华福证券:给予诺泰生物买入评级
证券之星 · 07-15
华福证券:给予诺泰生物买入评级
华福证券给予诺泰生物买入评级,GLP-1产业链率先获益,数吨级产能助力腾飞
每日经济新闻 · 07-15
华福证券给予诺泰生物买入评级,GLP-1产业链率先获益,数吨级产能助力腾飞
诺泰生物:董事会决定不提前赎回“诺泰转债”
每日经济新闻 · 07-11
诺泰生物:董事会决定不提前赎回“诺泰转债”
诺泰生物07月11日主力资金流出228万元 连续3日减仓
自选股智能写手 · 07-11
诺泰生物07月11日主力资金流出228万元 连续3日减仓
诺泰生物(688076)7月10日主力资金净卖出4761.12万元
证券之星 · 07-11
诺泰生物(688076)7月10日主力资金净卖出4761.12万元
诺泰生物(688076.SH):新建口服固体制剂车间硬胶囊剂生产线通过药品 GMP 符合性检查
格隆汇资讯 · 07-10
诺泰生物(688076.SH):新建口服固体制剂车间硬胶囊剂生产线通过药品 GMP 符合性检查
非酒精性脂肪性肝炎(NASH)概念盘中跳水,诺泰生物跌4.05%
自选股智能写手 · 07-10
非酒精性脂肪性肝炎(NASH)概念盘中跳水,诺泰生物跌4.05%
诺泰生物(688076)151.88万股限售股将于7月10日解禁,占总股本0.7%
证券之星 · 07-10
诺泰生物(688076)151.88万股限售股将于7月10日解禁,占总股本0.7%
北向资金7月8日净卖出诺泰生物18.63万股 连续3日减持
自选股智能写手 · 07-09
北向资金7月8日净卖出诺泰生物18.63万股 连续3日减持
5家药企预计上半年净利润增超50%,包括川宁生物、诺泰生物、誉衡药业等
中国制药网 · 07-08
5家药企预计上半年净利润增超50%,包括川宁生物、诺泰生物、誉衡药业等
非酒精性脂肪性肝炎(NASH)概念盘中跳水,微芯生物跌2.86%
自选股智能写手 · 07-08
非酒精性脂肪性肝炎(NASH)概念盘中跳水,微芯生物跌2.86%
加载更多
公司概况
公司名称:
江苏诺泰澳赛诺生物制药股份有限公司
所属行业:
医药制造业
上市日期:
2021-05-20
主营业务:
江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药进行自主研发与定制研发生产相结合的生物医药企业。公司的主要产品为阿托伐他汀钙片、氨氯地平阿托伐他汀钙片、利拉鲁肽、司美格鲁肽、苯甲酸阿格列汀、比伐芦定、依替巴肽、醋酸兰瑞肽、醋酸奥曲肽、磷酸奥司他韦、胸腺法新、GLP-1/GIP/GCG受体多靶点激动剂1类新药、氟维司群。
发行价格:
15.57
{"stockData":{"symbol":"688076","market":"SH","secType":"STK","nameCN":"诺泰生物","latestPrice":69.51,"timestamp":1721631600000,"preClose":68.22,"halted":0,"volume":3579821,"delay":0,"floatShares":218000000,"shares":218000000,"eps":0.9545,"marketStatus":"已收盘","marketStatusCode":5,"change":1.29,"latestTime":"07-22 15:00:00","open":68.22,"high":70.88,"low":67.81,"amount":249000000,"amplitude":0.045,"askPrice":69.55,"askSize":6,"bidPrice":69.51,"bidSize":18,"shortable":0,"etf":0,"ttmEps":0.9545,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":68.22,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":75.04,"lowLimit":61.4,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":218198791,"pbRate":7.19,"roa":"--","roe":"3.0%","epsLYR":0.76,"committee":0.419689,"marketValue":15167000000,"floatMarketCap":15167000000,"peRate":72.823466,"changeRate":0.0189,"turnoverRate":0.0164,"status":0,"afterMarket":{"amount":0,"volume":0,"close":69.51,"buyVolume":0,"sellVolume":0,"time":1721633637153,"indexStatus":"已收盘 07-22 15:30:00","preClose":68.22}},"requestUrl":"/m/hq/s/688076","defaultTab":"news","newsList":[{"id":"2453788328","title":"北向资金7月19日净卖出诺泰生物38.13万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453788328","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453788328?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:30","pubTimestamp":1721611837,"startTime":"0","endTime":"0","summary":"7月19日,北向资金减持诺泰生物38.13万股连续5日减持。截止当日收盘,沪股通共持有诺泰生物279.00万股,占流通股1.26%。沪股通减持金额前五个股分别为XD长江电、兴业银行、国电南瑞、山西汾酒、澜起科技。诺泰生物近5个交易日下跌1.62%,沪股通累计减持155.45万股;近20个交易日下跌11.29%,沪股通累计增持97.41万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220935089edd4f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220935089edd4f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2452496951","title":"新冠药物概念盘中跳水,诺泰生物跌0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452496951","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452496951?lang=zh_cn&edition=full","pubTime":"2024-07-19 10:02","pubTimestamp":1721354552,"startTime":"0","endTime":"0","summary":"07月19日,新冠药物概念盘中跳水,截至10点02分,新冠药物概念整体指数下跌1.01%,报441.540点。从个股上来看,该概念的成分股中,诺泰生物跌0.13%,众生药业、泰恩康跌幅居前。从资金上来看,截止发稿,新冠药物概念主力净流入为-4950.01万,其中ST百灵受到资金热捧,主力净流入2667.57万;拉长时间线来看,该板块近20日主力资金净流入-24.00亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407191002329681e41b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407191002329681e41b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2452982484","title":"CRO概念盘中跳水,诺泰生物跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452982484","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452982484?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:39","pubTimestamp":1721353154,"startTime":"0","endTime":"0","summary":"07月19日,CRO概念盘中跳水,截至09点39分,CRO概念整体指数下跌1.04%,报325.940点。从个股上来看,该概念的成分股中,诺泰生物跌0.48%,诚达药业、圣诺生物、万邦医药跌幅居前。从资金上来看,截止发稿,CRO概念主力净流入为-4146.66万,其中康龙化成受到资金热捧,主力净流入167.35万;拉长时间线来看,该板块近20日主力资金净流入-25.96亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719093914941f8791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719093914941f8791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2452467691","title":"非酒精性脂肪性肝炎(NASH)概念盘中跳水,微芯生物跌2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452467691","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452467691?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:52","pubTimestamp":1721267538,"startTime":"0","endTime":"0","summary":"07月18日,非酒精性脂肪性肝炎(NASH)概念盘中跳水,截至09点52分,非酒精性脂肪性肝炎(NASH)概念整体指数下跌0.72%,报972.240点。从个股上来看,该概念的成分股中,微芯生物跌2.07%,福瑞股份、众生药业、诺泰生物跌幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-659.10万,其中诺泰生物受到资金热捧,主力净流入166.85万;拉长时间线来看,该板块近20日主力资金净流入-15.24亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180952189681ddf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180952189681ddf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","688321","BK0239"],"gpt_icon":0},{"id":"2452557145","title":"北向资金7月17日净卖出诺泰生物36.55万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452557145","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452557145?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:30","pubTimestamp":1721266236,"startTime":"0","endTime":"0","summary":"7月17日,北向资金减持诺泰生物36.55万股连续3日减持。截止当日收盘,沪股通共持有诺泰生物357.11万股,占流通股1.62%。沪股通减持金额前五个股分别为紫金矿业、长江电力、工业富联、洛阳钼业、中国铝业。诺泰生物近5个交易日下跌0.20%,沪股通累计减持100.08万股;近20个交易日上涨12.45%,沪股通累计增持229.90万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180935549f60ea1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180935549f60ea1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2452139329","title":"诺泰生物:实控人提议实施2024年度中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2452139329","media":"澎湃新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452139329?lang=zh_cn&edition=full","pubTime":"2024-07-17 17:57","pubTimestamp":1721210220,"startTime":"0","endTime":"0","summary":"江苏诺泰澳赛诺生物制药股份有限公司7月17日晚间公告,公司控股股东、实控人赵德中提议公司董事会在中期分红前提条件达成的情况下、在股东大会的授权范围内尽快实施2024年度中期分红方案,建议分红金额不超过2024年上半年归母净利润的30%。赵德中承诺将在公司董事会审议该等事项时投“赞成”票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171758299f5c89cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171758299f5c89cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2452136986","title":"诺泰生物最新公告:控股股东提议中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2452136986","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452136986?lang=zh_cn&edition=full","pubTime":"2024-07-17 17:50","pubTimestamp":1721209841,"startTime":"0","endTime":"0","summary":"诺泰生物公告,收到控股股东、实际控制人赵德中提议公司董事会在中期分红前提条件达成的情况下、在股东大会的授权范围内尽快实施2024年度中期分红方案,建议分红金额不超过2024年上半年归属于上市公司股东的净利润的30%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700037286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2452713575","title":"诺泰生物(688076.SH)实控人提议中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2452713575","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452713575?lang=zh_cn&edition=full","pubTime":"2024-07-17 17:45","pubTimestamp":1721209549,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺泰生物(688076.SH)公告,公司控股股东、实际控制人赵德中提议公司董事会在中期分红前提条件达成的情况下、在股东大会的授权范围内尽快实施2024年度中期分红方案,建议分红金额不超过2024年上半年归属于上市公司股东的净利润的30%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152099.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688076"],"gpt_icon":0},{"id":"2452513932","title":"诺泰生物:拟实施2024年中期分红 分红金额不超净利润30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452513932","media":"财通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452513932?lang=zh_cn&edition=full","pubTime":"2024-07-17 17:40","pubTimestamp":1721209200,"startTime":"0","endTime":"0","summary":"诺泰生物公告,公司控股股东、实际控制人赵德中提议在中期分红前提条件达成的情况下,尽快实施2024年度中期分红方案,建议分红金额不超过2024年上半年归属于上市公司股东的净利润的30%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171741099f5c73ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171741099f5c73ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076"],"gpt_icon":0},{"id":"2451664035","title":"华福证券:给予诺泰生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2451664035","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451664035?lang=zh_cn&edition=full","pubTime":"2024-07-15 11:56","pubTimestamp":1721015808,"startTime":"0","endTime":"0","summary":"华福证券有限责任公司盛丽华近期对诺泰生物进行研究并发布了研究报告《GLP-1产业链率先获益,数吨级产能助力腾飞》,本报告对诺泰生物给出买入评级,当前股价为68.49元。最新盈利预测明细如下:该股最近90天内共有13家机构给出评级,买入评级10家,增持评级3家;过去90天内机构目标均价为80.49。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500011118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076","161027"],"gpt_icon":0},{"id":"2451834668","title":"华福证券给予诺泰生物买入评级,GLP-1产业链率先获益,数吨级产能助力腾飞","url":"https://stock-news.laohu8.com/highlight/detail?id=2451834668","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451834668?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:33","pubTimestamp":1721007180,"startTime":"0","endTime":"0","summary":"华福证券07月14日发布研报称,给予诺泰生物(688076.SH,最新价:68.33元)买入评级。评级理由主要包括:1)定制类业务增长稳健,欧洲大客户订单助力加速;2)GLP-1产业链率先获益,公司积极扩产,拥抱趋势;3)制剂产能落地,奥司他韦颗粒剂获批,有望加速。风险提示:产能建设不及预期,多肽原料药订单不及预期,多肽原料药降价风险。AI点评:诺泰生物近一个月获得2份券商研报关注,买入1家。(文章来源:每日经济新闻)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150934319f4ba86e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150934319f4ba86e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161027","688076"],"gpt_icon":0},{"id":"2450335217","title":"诺泰生物:董事会决定不提前赎回“诺泰转债”","url":"https://stock-news.laohu8.com/highlight/detail?id=2450335217","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450335217?lang=zh_cn&edition=full","pubTime":"2024-07-11 17:00","pubTimestamp":1720688425,"startTime":"0","endTime":"0","summary":"鉴于“诺泰转债”自2024年6月21日起开始转股,转股时间相对较短,且考虑到公司募投项目建设及日常生产经营等资金需求,结合当前市场情况及公司实际,为保护投资者利益,公司董事会决定本次不行使“诺泰转债”的提前赎回权,不提前赎回“诺泰转债”,且在未来六个月内均不再行使提前赎回权。2023年1至12月份,诺泰生物的营业收入构成为:医药制造业占比99.92%。截至发稿,诺泰生物市值为151亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111700499f337036&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111700499f337036&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2450382252","title":"诺泰生物07月11日主力资金流出228万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450382252","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450382252?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:18","pubTimestamp":1720682284,"startTime":"0","endTime":"0","summary":"07月11日, 诺泰生物股价涨0.38%,报收69.40元,成交金额2.64亿元,换手率1.74%,振幅4.08%,量比0.82。诺泰生物今日主力资金净流出228万元,连续3日净流出,上一交易日主力净流出4415万元,今日环比减少94.84%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为47.62%,平均跌幅为2.87%。该股近5个交易日下跌1.87%,主力资金累计净流出6707万元,其中3个交易日为股价上涨时净流出;近20日主力资金累计净流出5.16亿元,其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071115243195a4685c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071115243195a4685c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2450873356","title":"诺泰生物(688076)7月10日主力资金净卖出4761.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450873356","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450873356?lang=zh_cn&edition=full","pubTime":"2024-07-11 08:21","pubTimestamp":1720657277,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月10日收盘,诺泰生物报收于69.14元,下跌4.13%,换手率2.55%,成交量5.56万手,成交额3.87亿元。近5日资金流向一览见下表:诺泰生物融资融券信息显示,融资方面,当日融资买入2618.91万元,融资偿还5623.58万元,融资净偿还3004.67万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100011425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2450869709","title":"诺泰生物(688076.SH):新建口服固体制剂车间硬胶囊剂生产线通过药品 GMP 符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2450869709","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450869709?lang=zh_cn&edition=full","pubTime":"2024-07-10 17:46","pubTimestamp":1720604807,"startTime":"0","endTime":"0","summary":"本次硬胶囊剂生产线通过药品GMP符合性检查,表明此生产线符合《药品生产质量管理规范》要求,具备商业化生产的资质,有利于大幅提升公司磷酸奥司他韦胶囊等产品的生产能力,进一步提升公司生产线的自动化水平,为产品质量控制及产能供应提供保障,对公司未来发展具有积极意义。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710174656959dea9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710174656959dea9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2450882500","title":"非酒精性脂肪性肝炎(NASH)概念盘中跳水,诺泰生物跌4.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450882500","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450882500?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:57","pubTimestamp":1720576631,"startTime":"0","endTime":"0","summary":"07月10日,非酒精性脂肪性肝炎(NASH)概念盘中跳水,截至09点57分,非酒精性脂肪性肝炎(NASH)概念整体指数下跌0.62%,报975.180点。从个股上来看,该概念的成分股中,诺泰生物跌4.05%,天士力跌幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-610.55万,其中迈瑞医疗受到资金热捧,主力净流入307.92万;拉长时间线来看,该板块近20日主力资金净流入-18.18亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100957119681b61a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100957119681b61a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2450500053","title":"诺泰生物(688076)151.88万股限售股将于7月10日解禁,占总股本0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450500053","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450500053?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:02","pubTimestamp":1720569732,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,诺泰生物于7月10日将有151.88万股限售股份解禁,为公司股权激励一般股份,占公司总股本0.7%。最近一年内,该股累计解禁6680.98万股,占总股本的30.62%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000012958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2450053192","title":"北向资金7月8日净卖出诺泰生物18.63万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450053192","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450053192?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:30","pubTimestamp":1720488636,"startTime":"0","endTime":"0","summary":"7月8日,北向资金减持诺泰生物18.63万股连续3日减持。截止当日收盘,沪股通共持有诺泰生物422.27万股,占流通股1.94%。沪股通减持金额前五个股分别为恒瑞医药、韦尔股份、中国船舶、中国中免、平高电气。诺泰生物近5个交易日下跌9.07%,沪股通累计增持32.28万股;近20个交易日上涨22.76%,沪股通累计增持200.96万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090935179f222953&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090935179f222953&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","BK0239"],"gpt_icon":0},{"id":"2449464977","title":"5家药企预计上半年净利润增超50%,包括川宁生物、诺泰生物、誉衡药业等","url":"https://stock-news.laohu8.com/highlight/detail?id=2449464977","media":"中国制药网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449464977?lang=zh_cn&edition=full","pubTime":"2024-07-08 13:53","pubTimestamp":1720418010,"startTime":"0","endTime":"0","summary":"据笔者不完全统计,截至目前,已披露上半年业绩预告的药企中,预计上半年净利润增超50%的除了川宁生物以外,还有 圣湘生物 、 千红制药 、 誉衡药业 、 诺泰生物 等。千红制药7月3日晚间发布2024年半年度业绩预告则显示,上半年预计公司实现净利润1.83亿元,同比预增53.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081358059f1ca62b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081358059f1ca62b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","301301","002437"],"gpt_icon":0},{"id":"2449748588","title":"非酒精性脂肪性肝炎(NASH)概念盘中跳水,微芯生物跌2.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449748588","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449748588?lang=zh_cn&edition=full","pubTime":"2024-07-08 13:00","pubTimestamp":1720414831,"startTime":"0","endTime":"0","summary":"07月08日,非酒精性脂肪性肝炎(NASH)概念盘中跳水,截至13点00分,非酒精性脂肪性肝炎(NASH)概念整体指数下跌2.01%,报977.030点。从个股上来看,该概念的成分股中,微芯生物跌2.86%,众生药业、华东医药、诺泰生物跌幅居前。从资金上来看,截止发稿,非酒精性脂肪性肝炎(NASH)概念主力净流入为-3940.23万,其中诺泰生物受到资金热捧,主力净流入907.64万;拉长时间线来看,该板块近20日主力资金净流入-16.32亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081300319681a7dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081300319681a7dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688321","688076"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-05-20","address":"江苏省连云港市连云区经济技术开发区临浦路28号","stockEarnings":[{"period":"1week","weight":0.0089},{"period":"1month","weight":-0.0961},{"period":"3month","weight":0.2669},{"period":"6month","weight":0.7763},{"period":"1year","weight":1.0573},{"period":"ytd","weight":0.5566}],"companyName":"江苏诺泰澳赛诺生物制药股份有限公司","boardCode":"AI0027","perCapita":"21876股","boardName":"医药制造业","registeredCapital":"21819万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药进行自主研发与定制研发生产相结合的生物医药企业。公司的主要产品为阿托伐他汀钙片、氨氯地平阿托伐他汀钙片、利拉鲁肽、司美格鲁肽、苯甲酸阿格列汀、比伐芦定、依替巴肽、醋酸兰瑞肽、醋酸奥曲肽、磷酸奥司他韦、胸腺法新、GLP-1/GIP/GCG受体多靶点激动剂1类新药、氟维司群。","serverTime":1721668193976,"listedPrice":15.57,"stockholders":"9974人(较上一季度减少3.67%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺泰生物(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺泰生物,688076,诺泰生物股票,诺泰生物股票老虎,诺泰生物股票老虎国际,诺泰生物行情,诺泰生物股票行情,诺泰生物股价,诺泰生物股市,诺泰生物股票价格,诺泰生物股票交易,诺泰生物股票购买,诺泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺泰生物(688076)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺泰生物(688076)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}